Anti-Vimentin Nanobody Decreases Glioblastoma Cell Invasion In Vitro and In Vivo.
Alja ZottelMetka NovakNeja ŠamecBernarda MajcSara ColjaMojca KatrašnikMiloš VittoriBarbara HrastarAna RotterAndrej PorčnikTamara Lah TurnšekRadovan KomelBarbara BreznikIvana JovčevskaPublished in: Cancers (2023)
In conclusion, our results suggest that anti-vimentin nanobody Nb79 is a promising tool to target glioblastoma cell invasion.
Keyphrases